Matches in Wikidata for { <http://www.wikidata.org/entity/Q92566707> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92566707 description "2020 թվականի հունվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q92566707 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92566707 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92566707 description "scientific article published on 10 January 2020" @default.
- Q92566707 description "wetenschappelijk artikel" @default.
- Q92566707 description "наукова стаття, опублікована 10 січня 2020" @default.
- Q92566707 name "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 name "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 type Item @default.
- Q92566707 label "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 label "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 prefLabel "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 prefLabel "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 P1433 Q92566707-60BFA37B-0B39-4121-A199-A9E574000DFE @default.
- Q92566707 P1476 Q92566707-CEF5295D-3EF3-4E74-8458-3F7887C6BC0B @default.
- Q92566707 P2093 Q92566707-693F86E7-8B5C-4A79-9C15-4219794547B9 @default.
- Q92566707 P2093 Q92566707-9D8D0DF1-75DF-4AFA-BA60-304EAFB5941E @default.
- Q92566707 P2093 Q92566707-C27403F3-F41C-4D27-8ED9-955C5442B468 @default.
- Q92566707 P304 Q92566707-B1D80FE9-48D9-4A71-B9CE-576944E3926E @default.
- Q92566707 P31 Q92566707-2C419EAA-FF53-4B16-87FD-04F43D82FC90 @default.
- Q92566707 P356 Q92566707-FCBB3F9F-DAE5-41D0-9A51-B69D8F22BE13 @default.
- Q92566707 P433 Q92566707-960B010F-E240-4C26-B785-A769549BB0FA @default.
- Q92566707 P478 Q92566707-3FFFDDE8-759A-442A-BA52-8D96BF2922B8 @default.
- Q92566707 P50 Q92566707-59F3ED36-6544-4A28-8F2D-349FC5022F0E @default.
- Q92566707 P50 Q92566707-E30DE5C8-1148-4D7D-AD0B-7C9DE65E8010 @default.
- Q92566707 P577 Q92566707-1873DE10-7D82-42A9-B627-896711F53E1F @default.
- Q92566707 P698 Q92566707-8D1E991F-24DB-4F2E-9AFC-07058BE6342D @default.
- Q92566707 P921 Q92566707-1E40595A-E7F7-4FDA-8D5D-0967B1717BB9 @default.
- Q92566707 P356 S11239-020-02037-3 @default.
- Q92566707 P698 31925665 @default.
- Q92566707 P1433 Q15766541 @default.
- Q92566707 P1476 "The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding" @default.
- Q92566707 P2093 "Geoffrey D Barnes" @default.
- Q92566707 P2093 "Jessica Das" @default.
- Q92566707 P2093 "Kristen Pogue" @default.
- Q92566707 P304 "636-643" @default.
- Q92566707 P31 Q13442814 @default.
- Q92566707 P356 "10.1007/S11239-020-02037-3" @default.
- Q92566707 P433 "4" @default.
- Q92566707 P478 "49" @default.
- Q92566707 P50 Q87063372 @default.
- Q92566707 P50 Q90363784 @default.
- Q92566707 P577 "2020-01-10T00:00:00Z" @default.
- Q92566707 P698 "31925665" @default.
- Q92566707 P921 Q414462 @default.